|
BE615511A
(enExample)
|
1961-03-25 |
|
|
|
|
NL292958A
(enExample)
|
1962-05-29 |
1900-01-01 |
|
|
|
GB8809205D0
(en)
|
1988-04-19 |
1988-05-25 |
Nye P C G |
Treatment of oedema
|
|
US5137871A
(en)
|
1989-07-28 |
1992-08-11 |
Regents Of The University Of California |
Treatment to reduce edema for brain and musculature injuries
|
|
DE4010536A1
(de)
*
|
1990-04-02 |
1991-10-10 |
Boehringer Mannheim Gmbh |
Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure
|
|
DE4113820A1
(de)
|
1991-04-27 |
1992-10-29 |
Boehringer Mannheim Gmbh |
Verwendung von torasemid zur behandlung von hirnoedemen
|
|
US5486530A
(en)
|
1991-04-27 |
1996-01-23 |
Boehringer Mannheim Gmbh |
Use of torasemide for the treatment of brain oedemas
|
|
US5741671A
(en)
|
1991-12-12 |
1998-04-21 |
The Johns Hopkins University |
Isolation cloning and expression of transmembrane water channel aquaporin 1(AQP1)
|
|
US5858702A
(en)
|
1991-12-13 |
1999-01-12 |
The Johns Hopkins University |
Isolation, cloning and expression of transmembrane water channel Aquaporin 5 (AQP5)
|
|
US5519035A
(en)
|
1993-07-02 |
1996-05-21 |
Cornell Research Foundation, Inc. |
Treatment of stroke or in anticipation of the occurrence of brain ischemia
|
|
US20060167110A1
(en)
|
1995-01-13 |
2006-07-27 |
Blume Cherly D |
Methods for treating cerebrovascular disease by administering desmethylselegiline
|
|
CA2243643A1
(en)
|
1996-11-18 |
1998-05-28 |
Susan Haas |
Methods and compositions for inducing oral tolerance in mammals
|
|
EP1005347A4
(en)
|
1997-08-06 |
2002-08-28 |
Smithkline Beecham Corp |
ANTAGONISTS OF THE RECEPTORS OF THE MONOCYTE MACROPHAGE FOR USE IN TREATING CARDIOVASCULAR DISEASES
|
|
US5905090A
(en)
|
1998-04-29 |
1999-05-18 |
Italfarmaco S.P.A. |
Analogues of the active metabolite of leflunomide
|
|
CO5180581A1
(es)
*
|
1999-09-30 |
2002-07-30 |
Pfizer Prod Inc |
Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
|
|
US6500809B1
(en)
|
1999-11-12 |
2002-12-31 |
Neuron Therapeutics, Inc. |
Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith
|
|
ES2211460T3
(es)
|
1999-12-10 |
2004-07-16 |
Pfizer Inc. |
Compuestos de 1,4-dihidropiridina sustituidos con un heteroalrilo de 5 miembros como antagonistas de la bradiquinina.
|
|
UA82827C2
(en)
|
2000-12-18 |
2008-05-26 |
|
Inhibitors against the production and release of inflammatory cytokines
|
|
US7872048B2
(en)
|
2004-09-18 |
2011-01-18 |
University Of Maryland, Baltimore |
Methods for treating spinal cord injury with a compound that inhibits a NCCa-ATP channel
|
|
US8980952B2
(en)
|
2002-03-20 |
2015-03-17 |
University Of Maryland, Baltimore |
Methods for treating brain swelling with a compound that blocks a non-selective cation channel
|
|
PT2438913T
(pt)
|
2002-03-20 |
2020-05-27 |
Us Veterans Affairs |
Canal de catiões não seletivos em células neurais e compostos que bloqueiam o canal para utilização no tratamento de edema cerebral
|
|
TW200410671A
(en)
|
2002-06-05 |
2004-07-01 |
Inst Med Molecular Design Inc |
Medicines for inhibiting the activation of AP-1
|
|
AU2003242131A1
(en)
|
2002-06-05 |
2003-12-22 |
Institute Of Medicinal Molecular Design, Inc. |
Immunity-related protein kinase inhibitors
|
|
CN101103977A
(zh)
|
2002-06-05 |
2008-01-16 |
株式会社医药分子设计研究所 |
糖尿病治疗药
|
|
CN1658855B
(zh)
|
2002-06-06 |
2010-04-28 |
株式会社医药分子设计研究所 |
O-取代羟基芳基衍生物
|
|
CN1658872B
(zh)
|
2002-06-06 |
2010-09-22 |
株式会社医药分子设计研究所 |
抗过敏药
|
|
EP1535610A4
(en)
|
2002-06-10 |
2008-12-31 |
Inst Med Molecular Design Inc |
THERAPEUTIC CANCER
|
|
EA010470B1
(ru)
*
|
2002-06-10 |
2008-08-29 |
Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. |
ИНГИБИТОРЫ АКТИВАЦИИ NF-kB
|
|
EA011707B1
(ru)
|
2002-06-11 |
2009-04-28 |
Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. |
Лекарственное средство для лечения нейродегенеративных заболеваний
|
|
WO2004006858A2
(en)
|
2002-07-15 |
2004-01-22 |
Myriad Genetics, Inc |
Compounds, compositions, and methods employing same
|
|
ES2398460T3
(es)
|
2003-02-06 |
2013-03-19 |
Queen's University Of Belfast |
Péptido antagonista del receptor B2 de bradiquinina proveniente de la piel de un anfibio
|
|
CA2523740C
(en)
|
2003-05-01 |
2012-05-15 |
Innogene Kalbiotech Pte Ltd |
Lactate containing pharmaceutical composition and uses thereof
|
|
JPWO2005007151A1
(ja)
|
2003-07-16 |
2006-08-31 |
株式会社医薬分子設計研究所 |
皮膚色素沈着の治療剤
|
|
EP1680411A2
(en)
|
2003-10-08 |
2006-07-19 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
|
|
US8467876B2
(en)
|
2003-10-15 |
2013-06-18 |
Rmx, Llc |
Breathing disorder detection and therapy delivery device and method
|
|
WO2005039556A1
(ja)
|
2003-10-29 |
2005-05-06 |
Institute Of Medicinal Molecular Design. Inc. |
血行再建術後の再狭窄又は再閉塞の治療及び／又は予防のための医薬
|
|
US7378509B2
(en)
|
2003-12-02 |
2008-05-27 |
Anesiva, Inc. |
NF-kappaB oligonucleotide decoy molecules
|
|
EP2359832A3
(en)
|
2004-09-18 |
2011-11-23 |
University of Maryland, Baltimore |
Therapeutic agents targeting the NCCA-ATP channel and methods of use thereof
|
|
US7601745B2
(en)
|
2004-09-27 |
2009-10-13 |
4Sc Ag |
Heterocyclic NF-kB inhibitors
|
|
KR20070111475A
(ko)
|
2005-01-04 |
2007-11-21 |
노파르티스 아게 |
만성 변비 환자에서 테가세로드의 효능을 확인하기 위한바이오마커
|
|
TWI462745B
(zh)
*
|
2005-04-28 |
2014-12-01 |
Takeda Pharmaceutical |
安定的乳化組成物
|
|
WO2007084464A2
(en)
|
2006-01-17 |
2007-07-26 |
The University Of North Carolina At Chapel Hill |
Water channel blockers and methods of use thereof
|
|
JP4273235B2
(ja)
*
|
2006-06-01 |
2009-06-03 |
国立大学法人 新潟大学 |
アクアポリン４阻害薬
|
|
CA2654000A1
(en)
|
2006-06-06 |
2008-05-22 |
Genentech, Inc. |
Anti-dll4 antibodies and methods using same
|
|
US20080014196A1
(en)
|
2006-06-06 |
2008-01-17 |
Genentech, Inc. |
Compositions and methods for modulating vascular development
|
|
US7671058B2
(en)
|
2006-06-21 |
2010-03-02 |
Institute Of Medicinal Molecular Design, Inc. |
N-(3,4-disubstituted phenyl) salicylamide derivatives
|
|
WO2008046014A1
(en)
|
2006-10-12 |
2008-04-17 |
Remedy Pharmaceuticals, Inc. |
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective ca++- activated atp-sensitive cation channels regulated by sur1 receptors
|
|
US10004703B2
(en)
|
2006-10-12 |
2018-06-26 |
Biogen Chesapeake Llc |
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA++ activated ATP-sensitive cation channels regulated by SUR1 channels
|
|
WO2008052190A2
(en)
|
2006-10-26 |
2008-05-02 |
Flynn Gary A |
Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
|
|
US9316633B2
(en)
|
2006-11-16 |
2016-04-19 |
The Regents Of The University Of California |
Methods for identifying inhibitors of solute transporters
|
|
WO2008067373A2
(en)
|
2006-11-28 |
2008-06-05 |
Alcon Research, Ltd. |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS
|
|
US20080214486A1
(en)
|
2006-11-28 |
2008-09-04 |
Alcon Manufacturing, Ltd. |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS
|
|
EP3103451A1
(en)
|
2007-01-12 |
2016-12-14 |
University of Maryland, Baltimore |
Targetting ncca-atp channel for organ protection following ischemic episode
|
|
BRPI0806774A2
(pt)
|
2007-01-16 |
2011-09-13 |
Ipintl Llc |
composição para tratamento de sìndrome metabólica
|
|
US20120183600A1
(en)
*
|
2007-01-16 |
2012-07-19 |
Chien-Hung Chen |
Novel composition for treating metabolic syndrome and other conditions
|
|
EP2114160B1
(en)
|
2007-02-09 |
2016-11-16 |
University of Maryland, Baltimore |
Antagonists of a non-selective cation channel in neural cells
|
|
AU2008216612B2
(en)
|
2007-02-17 |
2014-12-04 |
President And Fellows Of Harvard College |
Compositions and method for tissue preservation
|
|
WO2008133884A2
(en)
|
2007-04-23 |
2008-11-06 |
Combinatorx, Incorporated |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
CA2974689C
(en)
|
2007-06-22 |
2020-02-25 |
The United States Of America As Represented By The Department Of Veters Affairs |
Inhibitors of ncca-atp channels for therapy
|
|
EP2178531A4
(en)
*
|
2007-07-02 |
2012-01-11 |
Yu Ming |
METHODS AND COMPOSITIONS, TARGETS FOR COMBINED CANCER TREATMENTS
|
|
US20090239868A1
(en)
|
2007-10-23 |
2009-09-24 |
Institute Of Medical Molecular Design, Inc. |
Inhibitor of pai-1 production
|
|
BRPI0816560A2
(pt)
|
2007-10-23 |
2015-09-01 |
Inst Med Molecular Design Inc |
Método de inibição de produção de pai-1 método para prevenção ou melhora de uma doença causada por uma super-produção de pai-1"
|
|
US8277845B2
(en)
|
2007-12-04 |
2012-10-02 |
Remedy Pharmaceuticals, Inc. |
Formulations and methods for lyophilization and lyophilates provided thereby
|
|
GB0724340D0
(en)
|
2007-12-13 |
2008-01-30 |
Univ Dundee |
Novel Therapeutic Agents
|
|
CA2709784A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
US20110034560A1
(en)
|
2008-01-29 |
2011-02-10 |
Sven Jacobson |
Liquid formulations of compounds active at sulfonylurea receptors
|
|
US8211882B2
(en)
|
2008-03-08 |
2012-07-03 |
Richard Delarey Wood |
Glutamate receptor modulators and therapeutic agents
|
|
WO2009139925A1
(en)
|
2008-05-16 |
2009-11-19 |
Panacea Pharmaceuticals, Inc. |
Methods for the treatment of brain edema
|
|
WO2010033560A2
(en)
|
2008-09-16 |
2010-03-25 |
University Of Maryland, Baltimore |
Sur1 inhibitors for therapy
|
|
WO2010048273A2
(en)
|
2008-10-21 |
2010-04-29 |
President And Fellows Of Harvard College |
Methods and compounds for treatment of neurodegenerative disorders
|
|
GB0823366D0
(en)
|
2008-12-22 |
2009-01-28 |
Uni I Oslo |
Synthesis
|
|
WO2010079406A1
(en)
|
2009-01-12 |
2010-07-15 |
Purapharm International (Hk) Limited |
Compounds and uses thereof for treating inflammation and modulating immune responses
|
|
WO2010096627A1
(en)
|
2009-02-20 |
2010-08-26 |
Lisanti Michael P |
Therapeutics and methods for treating neoplastic diseases comprising determining the level of caveolin-1 and/or caveolin-2 in a stromal cell sample
|
|
BR112012022654A2
(pt)
|
2010-03-10 |
2016-11-01 |
Univ Florida |
modulação de aquaporinas com relaxina
|
|
EP2595633A4
(en)
|
2010-07-19 |
2014-01-22 |
Remedy Pharmaceuticals Inc |
METHOD FOR INTRAVENOUS ADMINISTRATION OF GLYBURID AND OTHER MEDICAMENTS
|
|
EP2598145A1
(en)
*
|
2010-07-28 |
2013-06-05 |
Boehringer Ingelheim International GmbH |
Pharmaceutical composition for treatment of respiratory and inflammatory diseases
|
|
US20110052678A1
(en)
|
2010-11-05 |
2011-03-03 |
Shantha Totada R |
Method for treating age related macular degeneration
|
|
WO2012125749A2
(en)
|
2011-03-14 |
2012-09-20 |
Io Therapeutics, Inc. |
INFLAMMATION AND AUTOIMMUNE DISORDER TREATMENT USING RARα SELECTIVE AGONISTS
|
|
LT2717883T
(lt)
*
|
2011-05-02 |
2017-04-25 |
Stichting Vumc |
Apsauga nuo endotelio barjero disfunkcijos, slopinant su abl susijusio geno (arg) tirozino kinazę
|
|
RU2461375C1
(ru)
*
|
2011-05-19 |
2012-09-20 |
Учреждение Российской академии медицинских наук Научно-исследовательский институт онкологии Сибирского отделения Российской академии медицинских наук (НИИ онкологии СО РАМН) |
Способ комбинированного лечения больных местно-распространенным раком желудка
|
|
WO2013152313A1
(en)
*
|
2012-04-05 |
2013-10-10 |
The Regents Of The University Of California |
Compositions and methods for treating cancer and diseases and conditions responsive to growth factor inhibition
|
|
EP2844345B1
(en)
|
2012-05-04 |
2022-08-03 |
The United States of America, as Represented by The Secretary, Department of Health and Human Services |
Modulators of the relaxin receptor 1
|
|
WO2013169939A2
(en)
*
|
2012-05-08 |
2013-11-14 |
Aeromics, Llc |
New methods
|
|
WO2015037659A1
(ja)
|
2013-09-13 |
2015-03-19 |
株式会社医薬分子設計研究所 |
水溶液製剤及びその製造方法
|
|
KR20160079109A
(ko)
|
2013-11-06 |
2016-07-05 |
에어로믹스, 인코포레이티드 |
새로운 조성물
|
|
SMT201800521T1
(it)
|
2013-12-13 |
2018-11-09 |
Vertex Pharma |
Profarmaci di piridonammidi utili come modulatori di canali del sodio
|
|
CA2966950A1
(en)
|
2014-11-13 |
2016-05-19 |
Aeromics, Inc. |
Novel methods
|
|
WO2016196113A1
(en)
|
2015-05-29 |
2016-12-08 |
University Of Maryland, Baltimore |
Methods of reducing or preventing intimal damage caused by mechanical stimulation of endothelial cells
|
|
BR112018006925A2
(pt)
|
2015-10-07 |
2018-10-16 |
Biogen Chesapeake Llc |
métodos de tratamento de lesões ou patologias associadas com um edema do snc
|
|
CN115093443A
(zh)
|
2016-05-13 |
2022-09-23 |
埃罗米克斯公司 |
晶体
|
|
CA3032294C
(en)
|
2016-07-29 |
2025-03-11 |
Biogen Chesapeake Llc |
MEDICAL TREATMENT METHODS WITH SUR1-TRPM4 CHANNEL INHIBITORS
|
|
JP2023536509A
(ja)
|
2020-08-05 |
2023-08-25 |
ジャンスー・シムセレ・ファーマシューティカル・カンパニー・リミテッド |
アクアポリン阻害剤の医薬組成物およびその製造方法
|